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Abstract
In cystic fibrosis (CF), the most frequent mutant variant of the cystic fibrosis transmembrane conductance regulator (CFTR),
F508del-CFTR protein, is misfolded and retained in the endoplasmic reticulum (ER). We previously showed that the
unfolded protein response (UPR) may be triggered in CF. Since prolonged UPR activation leads to apoptosis via the calcium-
calpain-caspase-12-caspase-3 cascade and because apoptosis is altered in CF, our aim was to compare the ER stress-induced
apoptosis pathway between wild type (Wt) and F508del-CFTR expressing cells. Here we show that the calcium-calpain-
caspase-12-caspase-3 cascade is altered in F508del-CFTR expressing cells. We propose that this alteration is involved in the
altered apoptosis triggering observed in CF.
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Introduction
Cystic fibrosis (CF)is the mostcommon lethalautosomal recessive
disease in the Caucasian population. It is due to mutations in the
cystic fibrosis transmembrane conductance regulator (CFTR) gene
[1–3].The most common mutation inCFis a missing phenylalanine
at position 508 (F508del-CFTR) in the first nucleotide-binding
domain of the CFTR protein. The misfolded F508del-CFTR
protein does not traffic correctly to the plasma membrane and is
degraded by proteasome [4–11]. Nevertheless, some F508del-
CFTR is retained in the endoplasmic reticulum (ER) [12]. Beside
the accumulation of F508del-CFTR in the ER, inflammation and
infection are the major features of CF [13]. Eukaryotic cells respond
to the accumulation of misfolded proteins in the ER, to
inflammation and infection by activating the unfolded protein
response (UPR) [14–15]. Some lines of evidence suggest that UPR is
triggered in F508del-CFTR expressing cells due to the mutated
protein itself or by exogenous factors [16–19]. UPR induces the
transcription of genes encoding ER chaperones, protein-folding
enzymes and components of the ER-associated degradation system,
limiting new protein synthesis [20–24]. Whereas it is an adaptive
process aimed to restore the ER homeostasis, it may lead to
apoptosis due to an increased intracellular calcium ([Ca
2+]i)c o n t e n t
followed bythe activationof the calpain(Cal-1and -2),caspase(Csp)
-12 and Csp-3 cascade [25–31].
Some studies have suggested perturbations in the apoptotic
process in CF cell lines. Whereas it was shown that high DNA
fragmentation, and likely apoptosis, is a feature of various epithelia
in CF it is now admitted that failure to undergo apoptosis could
contribute to the pathogenesis of the disease [32–35]. Therefore,
according to UPR triggering in CF, our aim was to assess whether
the [Ca
2+]i, Cal-1, Cal-2, Csp-12 and Csp-3 cascade activation
was modified in F508del-CFTR expressing cells when compared
to wt-CFTR expressing cells. The comparison was also studied
after UPR induction by thapsigargin (Tg). Using western blot
experiment and Csp activity measurement, our results indicate
that the cascade is altered in F508del-CFTR expressing cells.
Indeed, we observed a decreased basal expression of Cal-1, Csp-12
and Csp-3 in delF508 expressing cells. Under stress conditions, the
observed alterations were a lower expression of Cal-1, Cal-2,
active form of Csp-12 and the absence of increased accumulation
of the active form of Csp-3 in F508del-CFTR expressing cells.
Furthermore, the Csp-12 and Csp-3 activities were decreased as
well as the cells mortality. Therefore, we show that the altered
apoptosis observed in CF under stress conditions (inflammation,
infection) involves an altered Cal-1, Csp-12 and mostly Csp-3
activation.
Results
The first step of the studied cascade is a sustained increase in
intracellular free [Ca
2+] [27]. Therefore, we compared the basal
free [Ca
2+] between 16HBE14o- (wt-CFTR expressing cells) and
CFBE41o- cells (F508del-CFTR expressing cells), using Fura-2
AM as a probe. No difference between 16HBE14o- and
CFBE41o- cells regarding the basal [Ca
2+]i was observed (Fig. 1).
16HBE14o- and CFBE41o- cells were further submitted to Tg
treatment for 24, 30, 36 and 48 hours to induce ER stress. At the
24 hours time point the [Ca
2+]i level was increased in both cell
types indicating that the Tg treatment was efficient. The observed
increased [Ca
2+]i remained high until 48 hours. Nevertheless, the
increased [Ca
2+]i lower in CFBE41o- cells.
The Cal-1, Cal-2, Csp-12 and Csp-3 expressions without Tg
treatment were compared using western blottings in 16HBE14o-,
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The statistical analysis (Fig. 2B) showed that basal Cal-1, Csp-12
and Csp-3 expressions were decreased in CFBE41o- cells, whereas
the Cal-2 expression was not modified. After 24, 30, 36 and 48
hours of ER stress due to Tg, Cal-1, Cal-2, Csp-12, Csp-3
expressions were assessed in the three cell types using western
blottings (Fig. 3A). Cal-1 expression was increased in all the cell
types after 24 hours treatment and remained higher than in the
Figure 1. Comparison of the [Ca
2+]i between 16HBE14o- and
CFBE41o- cells. 16HBE14o- and CFBE41o- cells were loaded with Fura-
2 AM and fluorescence was recorded at 340 nm (saturated calcium) and
380 nm (free calcium). The 340/380 nm ratio was calculated and
compared between the two cell types at increasing times of Tg
treatment. Whereas no significant difference was observed between the
two cell types in the absence of Tg (0 time point), [Ca
2+]i was increased
in 16HBE14o- and CFBE41o- cells after 24 hours treatment. A significant
lower [Ca
2+]i was observed in the F508del-CFTR expressing cells. Bars
represent SEM (n=9).
doi:10.1371/journal.pone.0008436.g001
Figure 2. Expression of Cal-1, Cal-2, Csp-12 and Csp-3 in
16HBE14o-, CFBE41o- corr and CFBE41o- cells. A. Example of
western blots showing the expression of Cal-1, Cal-2, pro-Csp-12, pro-
Csp-3 and actin in 16HBE14o-, CFBE41o- corr and CFBE41o- cells. B.
Histograms represent the quantification of Cal-1, Cal-2, pro-Csp-12 and
pro-Csp-3 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells The
statistical analysis indicates a significant decreased of Cal-1, pro-Csp-
12 and pro-Csp-3 in CFBE41o- cells. Bars represent SEM (n=7).
doi:10.1371/journal.pone.0008436.g002
Figure 3. Expression of Cal-1, Cal-2, active Csp-12 and active
Csp-3 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells in the
presence of Tg. A. Example of western blots showing the expression
of Cal-1, active Csp-12, active Csp-3 and actin in 16HBE14o- (1, 4, 7, 10,
13), in CFBE41o- corr cells (2, 5, 8, 11, 14) and CFBE41o- cells (3, 6, 9, 12,
15) at different time point of Tg treatment. B. Histogram represents the
quantification of Cal-1 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells
in the absence (0 time point) and after 24, 30, 36 and 48 hours
induction by Tg. In all cell types the Cal-1 is increased in the presence of
Tg. The increased expression of Cal-1 is lower in CFBE41o- cells. At the
30 time point the difference is abolished. Bars represent SEM (n=7). C.
Histogram represents the quantification of Cal-2. In all cell types the Cal-
2 is increased in the presence of Tg. The increased expression of Cal-1 is
lower in CFBE41o- cells. Bars represent SEM (n=7). D. Result of the
statistical analysis of the active Csp-12 expression when Tg was applied
on the cells. It indicates that the active Csp-12 is overexpressed in all cell
types after Tg treatment. The overexpression is lower in F508del-CFTR
expressing cells. Bars represent SEM (n=7). E. The-quantification of the
active Csp3 was performed using an ELISA kit as described in the
methods. The histogram represents statistical analysis of the optical
densities (OD, 450 nm) which are proportional to the quantity of the
cleaved-Csp-3 in the cell lysates. It is observed that in 16HBE14o- and
CFBE41o- corr cells the cleaved form is increased after 24 hours of Tg
treatment whereas it is increased in CFBE41o- cells after 48 hours.
Nevertheless, the amount of the cleaved-Csp-3 remains lower in
CFBE41o- cells. Bars represent SEM (n=6).
doi:10.1371/journal.pone.0008436.g003
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Cal-1 expression was lower in the F508del-CFTR expressing cells.
After 48 hours treatment the Cal-1 expression was identical in
16HBE14o- and CFBE41o- cells, indicating that F508del-CFTR
expressing cells needed a longer time to respond to Tg. No
difference was observed between 16HBE14o- and CFBE41o-corr
cells. After 24 hours of Tg treatment, Cal-2 expression was
increased in all cell types but this increased expression remained
lower in CFBE41o- cells (Fig. 3C). Therefore we concluded that
F508del-CFTR cells exhibit an altered Cal-2 regulation when Tg is
applied on the cells. The cleavage of Csp-12 in16HBE14o-,
CFBE41o- and in CFBE41o-corr cells was studied using western
blottings. The statistical analysis showedthat the activeform of Csp-
12 was increased 24 hours after Tg treatment and reached a
maximum after 30 hours in all cell types (Fig. 3D). The
accumulation of the active form of Csp-12 was lower in F508del-
CFTR expressing cells showing that the appearance of the cleaved
form of Csp-12 is delayed when F508del-CFTR is expressed. In
16HBE14o- and in CFBE41o- corr cells the accumulation of the
active form of Casp-3 was increased at 24 hours of treatment and
progressively increased to reach a maximum after 36 hours of
treatment (Fig. 3E). This pattern of expression was correlated to a
decreased full length Csp-3 expression (not shown). In CFBE41o-
cells, the Csp-3 expression was lower than in 16HBE14o- and
CFBE41o- corr cells. In CFBE41o- cells, no accumulation of the
active form of Csp-3 was observed before 48 hours of Tg treatment,
indicating an important Csp-3 alteration (Fig. 3E). The full length
Csp-3 expression was not modified in these cells at any time point
(not shown). Therefore, under Tg treatment, Cal-1, Cal-2 and
active Csp-12 accumulation were lower and delayed in CFBE41o-
cells when compared to that of 16HBE14o- and CFBE41o- corr
cells. The most significant result was a delayed and lower increased
expression of the active form of Csp-3 in CFBE41o- cells after
Tg stress.
Csp-12 and Csp-3 activities were measured by a fluorometric kit
assay. For statistical analysis, the basal activities after 1 hour of Tg
treatment (time point O) were chosen as 1 unit activity. Casp-12
basal activity was found to be decreased in CFBE41o- cells when
compared to that of 16HBE14o- and CFBE41o- corr cells
(Fig. 4A). Nevertheless, under Tg treatment the Csp-12 activity
increased in all cell types. 36 hours after Tg treatment this activity
was lower in F508del-CFTR expressing cells which exhibited a
level corresponding to the non treated CFBE41o- and CFBE41o-
corr cells. Therefore, this result suggested that F508del-CFTR
expressing cells exhibit a decreased duration of Csp-12 activation
when compared to CFTR expressing cells. Csp-3 activation was
observed in 16HBE14o- and in CFBE41o- corr cells 24 hours after
Tg treatment. The plateau phase observed after 24 hours was
likely due to a sufficient amount of active Csp-3 to clive the whole
substrate, showing that the maximal activity was reached. In
CFBE41o- cells the basal Csp-3 activity was lower than in
16HBE14o- and CFBE41o- corr cells (Fig. 4B). Under Tg
treatment despite increased [Ca
2+]i, Cal-1, Cal-2 and Csp-12
levels and despite an increased Csp-12 activity, the Csp-3 activity
was hardly detected and remained very low. This result was in
accordance with accumulation of the active form of Csp-3
detected by ELISA.
Cal and Csp-12 activation are hallmarks of apoptosis [36–40].
We assessed the cell viability of 16HBE14o-, in CFBE41o- corr
and CFBE41o- cells under Tg conditions. As shown in Fig. 5, the
mortality was decreased in CFBE41o- cells independently of any
treatment. After 36 hours of Tg treatment, the number of dead
16HBE14o- and CFBE41o- corr cells was increased and reached
80% (+/2 10%) at the 48 hours time point. Increased mortality
was found in CFBE41o- cells. Nevertheless, the percentage of dead
16HBE14o- and CFBE41o- corr cells was higher than that of
CFBE41o- cells (30% +/2 55%) at the 48 hours induction point.
Therefore, a decreased cell death was observed in the F508del-
CFTR expressing cells.
Discussion
Mutations in the gene encoding CFTR are responsible for CF.
The most common mutation F508del-CFTR, whose pathology is
Figure 4. Activities of Csp-12 and Csp-3 in 16HBE14o-,
CFBE41o- corr and CFBE41o- cells in the presence of Tg.
Activities were measured by a fluorometric kit and the fluorescence
after 1 hour incubation of 16HBE14o- cells with Tg was taken as
reference. A. Histogram representing the results for the Csp-12 activity.
The activity was increased in all cell types after 24 hours Tg. It was
decreased in CFBE41o- cells at 48 hours. Bars represent SEM (n=5). B.
Histogram representing the results for the Csp-3 activity. It was
increased in 16HBE14o- and CFBE41o- corr cells at the 24 hours time
point and remained sustained until 48 hours. In CFBE41o- cells the Csp-
3 activity was low and no increase among Tg incubation time was
observed. Bars represent SEM (n=6).
doi:10.1371/journal.pone.0008436.g004
Figure 5. Percentage of mortality in 16HBE14o- and CFBE41o-
cells in the presence of Tg. The curves represent the mortality time
course under Tg treatment. In both cell types it was increased with
time. Nevertheless, the mortality was higher in 16HBE14o- and
CFBE41o- corr cells after 36 hours of Tg treatment (p,0.001). Bars
represent SEM (n=5).
doi:10.1371/journal.pone.0008436.g005
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The associated pathology is maintained by repeated lung
infections, which provokes inflammatory responses that lead to
lung fibrosis and respiratory failure in which lung necrosis is
involved [41]. Furthermore, infected epithelial cells expressing
mutant CFTR are less sensitive to apoptosis than cells expressing
normal CFTR [35]. Because the released debris by cells
undergoing necrosis initiate inflammatory response which is
harmful in CF, it is important to understand why cells expressing
mutant CFTR are more resistant to apoptosis than normal cells in
the absence of infection. Consistent with this view, are the typical
large DNA fragments of necrotic cells which are released by CF
epithelia, increasing the viscosity of the mucus.
Beside the decreased Cl
2 permeability, the misfolded F508del-
CFTR is partially retained in the ER where it activates UPR
which can be enhanced by infection and inflammation [12,14–19].
Indeed, UPR triggering due to the mutated CFTR expression was
observed in A549 cells as well as in CFBE41o- cells which were
used in the present study [17,18]. It has been proposed that
multiple UPR pathways contribute to ER stress-induced cell
apoptosis, although the mechanisms still remain largely unknown.
Nevertheless, the involvement of the [Ca
2+]i, Cal-1 and -2, Csp -
12 and Csp-3 cascade is suggested [25–31]. Therefore, our aim
was to study this cascade in wt- and F508del-CFTR expressing
cells and we showed that this pathway is altered when the mutated
CFTR is expressed. Indeed, we observed decreased Cal-1 and Csp
expressions in CF cells. Furthermore, we showed that under stress
condition which was performed to mimic the exogenous stress
observed in CF, Csp decreased expressions in CF cells were
accompanied by a decreased activity, mostly regarding Csp-3
(Fig. 6). Interestingly, calpains deficiency was correlated with the
resistance to ER stress-induced apoptosis which was directly
related to a calpain requirement for the activation of Csp-12 and
our results are consistent with previous studies showing that
deficient cells for the pro-Csp-12 are resistant to ER stress-induced
apoptosis [27,28]. Nevertheless the present data regarding Csp-12
have to be moderated because its involvement in UPR in human is
still controversial [42–44]. Indeed, previous data in humans and
rodents indicate that the presence of Csp-12 attenuates respon-
siveness to bacterial invasion and confers a survival disadvantage
[45].
In conclusion, we suggest that the [Ca
2+]i, Cal-1 and -2, Csp -12
and Csp-3 cascade in involved in the CF physiopathology because
this cascade is altered in CF cells and that the most important
alteration concerns Csp-3. Therefore, the present results provide
new fields of investigation regarding the altered apoptosis observed
in CF.
Materials and Methods
Antibodies and Drugs
Monoclonal anti-Cal-1 (9A4H8D3, ab3589) and polyclonal
anti-Cal-2 (2539) were purchased from abcam and Cell Signaling,
respectively. Polyclonal anti-Csp-12 (2202) and monoclonal anti-
Csp-3 (9662) were purchased from Cell Signaling. Secondary
antibodies and the ECL+ detection kit were purchased from
Amersham. Tg (T9033) and protease inhibitor cocktail (P8849)
were from Sigma. Csp-12 Fluorometric Assay Kit (K139-100) and
Csp-3 Fluorometric Assay Kit (K105-100) were from Biovision
and were used to study the activity of these Csp.
Cell Culture and Treatment
Pr. D.C. Gru ¨enert (San Francisco, CA, U.S.A) kindly provided
the normal human bronchial polarized epithelial cells 16HBE14o-
expressing the normal CFTR, their CF counterparts CFBE41o-
expressing the F508del-CFTR and the corrected CFBE41o- cells
[46–50]. The cells were cultured in Eagle’s minimal essential
medium (MEM) supplemented with 10% FBS and glutamine on
an extracellular matrix (CellBind Corning, Bioblock). To induce
ER calcium depletion and the activation of the [Ca
2+]i, Cal-1, Cal-
2, Csp-12 and Csp-3 cascade, cells were treated with 5 mM Tg for
24, 30, 36 and 48 hours.
Viability Assays
Cell viability after Tg treatment was determined by trypan blue
exclusion. Cells were trypsinized, resuspended in phosphate buffer
saline (PBS), incubated with 0.4% trypan blue (prepared in PBS)
for 8 min and counted (at least 600) for calculation of percentage
of residual cell viability, as previously described [26].
Fura 2-AM Measurement
[Ca
2+]i in 16HBE14o- and CFBE41o- cells with and without Tg
treatment was measured using the Ca
2+-sensitive fluorescent probe
fura-2 acetoxy-methyl ester (Fura-2 AM, Invitrogen). Cells were
loaded for 45 min in the dark with 2.5 mM Fura-2 AM at 37uC.
They were rinsed twice and incubated in Tyrode solution for 20
min at 37uC. Fluorescence was recorded using the fluorescence
microscope (IX-71, Olympus, France) at 340 nm (saturated Ca
2+)
and 380 nm (free Ca
2+) and was further analyzed using Fluostar
software (IMSTAR, France). For each experiment, 20–30 cells
were observed, the responses were compared to the controls
obtained with untreated cells and the [Ca
2+]i concentration was
calculated as previously described [51].
Protein Extraction and Western Blotting
Cell lysates were prepared from 16HBE14o- and CFBE41o-
cells in lysis buffer (50 mM Tris HCl, 100 mM NaCl, 1% Triton
X-100) in the presence of protease inhibitor cocktail (5 mL/mL;
1.1 mM leupeptin, 0.7 mM aprotinin, 120 mM PMSF, 1 mM
iodoacetamide, 0.7 mM pepstatin and 1 mM DIFP). Protein
concentrations were determined by the method of Lowry et al.
using bovine serum albumine as a standard [50]. Equal amounts of
total proteins for each sample were submitted to 37uc heating and
subjected to SDS/PAGE (12%). After blotting, the membranes
were saturated in PBS containing 0.2% fat free milk, incubated
overnight (4uc) with anti-Cal-1 (1/1000), anti-Cal-2 (1/1000), anti-
Csp-12 (1/500) and anti-Csp-3 (1/500) antibodies and with
Figure 6. Schematic presentation of molecular mechanisms
involving calpains and caspases leading to apoptosis in
F508del-CFTR expressing cells. This schematic representation is
adaptated from [27]. Black arrows indicate the pathway in CFTR
expressing cells. In dark grey are our proposed modifications in
F508del-CFTR expressing cells.
doi:10.1371/journal.pone.0008436.g006
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performed using an ECL+ detection kit. Densitometric analysis
of the signals was performed using a GelDoc 2000 apparatus
(Biorad) and each value was normalized by the total amount of
loaded proteins per lane which was estimated after coomassie blue
staining of the membrane and by the actin signal obtained on the
same membranes, which did not vary among cell types.
Cleaved Csp-3 Detection
A solid phase sandwich enzyme-linked immunosorbent assay
(ELISA, Cell Signaling) was used to detect and quantify the
cleaved Csp-3, according to the manufacturer’s instructions. In
this assay, a total Csp-3 antibody is coated onto microwells. After
incubation with the cell lysates, cleaved and uncleaved Csp-3 is
captured. Following extensive washing a biotinylated cleaved-Csp-
3 antibody is used to specifically detect this form of the protein.
The magnitude of optical density (OD, 450 nm) of the coloured
reaction is proportional to the quantity of cleaved-Csp-3 (17 kDa).
All time points were performed in triplicate and the experiment
was performed three times.
Caspases Activities Assays
Csp-12 and Csp-3 activities were measured by a fluorometric kit
assay according to manufacturer’s instructions. In brief, cells were
lysed and the proteins (20 mg) were incubated with the Csp-12
substrate ATAD-AFC (50 mg) or with the Csp-3 substrate
DEVAD-AFC (50 mg), for 2 hours at 37uC. Samples are
transferred in black bottom 96 wells microplates and were read
in a fluorescence microplate reader (Fluoroskan Ascent; Labsys-
tems). The non-clived substrate emission was 400 nm (blue) and
the clived substrate emission was 505 nm (green). The control
reactions were performed with no protein in the wells and by
omitting the substrate. Experiments were performed in triplicate.
Statistical Analysis
Data are shown as mean 6 standard error of mean (SEM).
Differences between experimental groups were evaluated by a
two-tailed unpaired Student’s t test. p,0.05 was considered
significant (*), p,0.001 was considered very significant (**) and
p,0.0001 was considered highly significant.
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